Mitochondrial (MT) dysfunction is a factor in numerous chronic diseases and the toxicity related to environmental exposures, but early deficits in MT function are difficult to detect. Current clinical markers for mitochondrial dysfunction typically detect only advanced symptoms of tissue injury and disease, yet the sensitivity to detect mild MT dysfunction and heterogeneity within tissue has hampered robust identification of meaningful biomarkers at early stages. Mitochondrial biology is variable;and chronic, low level MT dysfunction may be below the detection sensitivity of many techniques. As a result there is the need of new tools to enhance the mechanistic understanding of environmentally-induced mitochondrial toxicity at early stages to enable prevention and intervention. To address this problem, this team of investigators has developed and applied a new technology for single cell mass spectrometry, called Nanostructure-Initiator Mass Spectrometry (NIMS). NIMS has both the single cell resolution (1-10 5m) and the high sensitivity (attomolar) needed to detect early biomarkers of MT dysfunction as metabolic """"""""signatures"""""""" in individual cells. NIMS offers a number of advantages over standard mass spectrometry, including (1) ultra-high sensitivity, (2) high selectivity, and (3) single cell resolution to reduce sample complexity. NIMS will be applied to identify metabolic signatures for early MT dysfunction in the brain and blood of diseased animals or animals treated with environmental toxins at """"""""subclinical"""""""" levels.
In Specific Aim 1, NIMS will be employed to generate metabolic signatures for MT decline.
In Specific Aim 2, an activity test will be used to see whether the biomarker reflects functional changes in MT or MT within the context of the cell. NIMS can be applied to any tissue and any cell type, to quantitatively sort out complex changes that occur in dynamic cellular environments, and minimizes the inherent system heterogeneity that has confounded efforts in detecting meaningful markers of MT decline.

Public Health Relevance

Mitochondrial dysfunction is a factor in numerous chronic diseases and environmental exposures, but early deficits in MT function are difficult to detect. To address this problem, we have developed and applied a new technology for single cell mass spectrometry, called NIMS. NIMS has both single cell resolution and the high sensitivity needed to detect early biomarkers of MT dysfunction, and will be used to define """"""""signatures"""""""" of early MT dysfunction in single cells. Thus, NIMS technology reduces system heterogeneity, has the high sensitivity needed for detecting meaningful metabolic markers of early MT decline, and the ability to spatially assign signatures in distinct cell types. We apply NIMS identify the effects of oxidative damage in the brain, blood and urine in animal models.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
1R01ES020766-01
Application #
8218086
Study Section
Special Emphasis Panel (ZES1-LWJ-J (MI))
Program Officer
Shaughnessy, Daniel
Project Start
2011-09-20
Project End
2016-06-30
Budget Start
2011-09-20
Budget End
2012-06-30
Support Year
1
Fiscal Year
2011
Total Cost
$440,164
Indirect Cost
Name
Lawrence Berkeley National Laboratory
Department
Genetics
Type
Organized Research Units
DUNS #
078576738
City
Berkeley
State
CA
Country
United States
Zip Code
94720
Polyzos, Aris A; McMurray, Cynthia T (2017) The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington's disease. Mech Ageing Dev 161:181-197
Polyzos, Aris A; McMurray, Cynthia T (2017) Close encounters: Moving along bumps, breaks, and bubbles on expanded trinucleotide tracts. DNA Repair (Amst) 56:144-155
Polyzos, Aris; Holt, Amy; Brown, Christopher et al. (2016) Mitochondrial targeting of XJB-5-131 attenuates or improves pathophysiology in HdhQ150 animals with well-developed disease phenotypes. Hum Mol Genet 25:1792-802
Budworth, Helen; McMurray, Cynthia T (2016) Problems and solutions for the analysis of somatic CAG repeat expansion and their relationship to Huntington's disease toxicity. Rare Dis 4:e1131885
Lai, Yanhao; Budworth, Helen; Beaver, Jill M et al. (2016) Crosstalk between MSH2-MSH3 and pol? promotes trinucleotide repeat expansion during base excision repair. Nat Commun 7:12465
Budworth, Helen; Harris, Faye R; Williams, Paul et al. (2015) Suppression of Somatic Expansion Delays the Onset of Pathophysiology in a Mouse Model of Huntington's Disease. PLoS Genet 11:e1005267
Trushina, Eugenia; Canaria, Christie A; Lee, Do-Yup et al. (2014) Loss of caveolin-1 expression in knock-in mouse model of Huntington's disease suppresses pathophysiology in vivo. Hum Mol Genet 23:129-44
McMurray, Cynthia T; Vijg, Jan (2014) Editorial overview: Molecular and genetic bases of disease: the double life of DNA. Curr Opin Genet Dev 26:v-vii
Lee, Do-Yup; McMurray, Cynthia T (2014) Trinucleotide expansion in disease: why is there a length threshold? Curr Opin Genet Dev 26:131-40
Lee, Do Yup; Xun, Zhiyin; Platt, Virginia et al. (2013) Distinct pools of non-glycolytic substrates differentiate brain regions and prime region-specific responses of mitochondria. PLoS One 8:e68831

Showing the most recent 10 out of 16 publications